Lu-165Homo sapiens (Human)Cancer cell line

Also known as: LU165, LU-165

🤖 AI SummaryBased on 4 publications

Quick Overview

Human small cell lung cancer cell line producing ADH.

Detailed Summary

Lu-165 is a human small cell lung cancer (SCLC) cell line established from a 50-year-old Indonesian male patient with syndrome of inappropriate antidiuretic hormone secretion (SIADH). This cell line is notable for its high production of anti-diuretic hormone (ADH), with levels reaching 2.8 mg/g protein. Lu-165 cells exhibit a suspended growth pattern and show immunoreactivity for ADH in the cytoplasm. The cell line has been used in studies to investigate the biochemical and morphological characteristics of ADH-producing SCLC, as well as the mechanisms of ADH production and regulation. It has also been utilized in transplantation studies to evaluate tumor growth in nude mice. The cell line is part of a collection of SCLC cell lines that have been characterized for their genetic and molecular profiles, contributing to the understanding of SCLC biology and potential therapeutic targets.

Research Applications

ADH production and regulationSCLC biologyTumor transplantation in nude miceGenetic and molecular profiling

Key Characteristics

High ADH productionSuspended growth patternCytoplasmic ADH immunoreactivityEstablished from SIADH patient
Generated on 6/16/2025

Basic Information

Database IDCVCL_1391
SpeciesHomo sapiens (Human)
Tissue SourceLymph node[UBERON:UBERON_0000029]

Donor Information

Age50
Age CategoryAdult
SexMale

Disease Information

DiseaseSmall cell lung cancer
LineageLung
SubtypeSmall Cell Lung Cancer
OncoTree CodeSCLC

DepMap Information

Source TypeRIKEN
Source IDACH-002077_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Val157Profs*9 (c.468_480delCGTCCGCGCCATG)Heterozygous-Unknown, Unknown
MutationSimplePTENp.Gly36Arg (c.106G>A)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,12
D13S317
10
D16S539
9,11
D5S818
9,13
D7S820
12
TH01
9
TPOX
8,9
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan.

Kasai F., Fukushima M., Miyagi Y., Nakamura Y.

Hum. Cell 37:944-950(2024).

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

Inazawa J.

Am. J. Pathol. 161:207-216(2002).

Establishment of a human small cell lung cancer cell line producing a large amount of anti-diuretic hormone.

Nagatsu T., Kato K.

Jpn. J. Cancer Res. 85:718-722(1994).